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ABSTRACT:
Creutzfeldt-Jakob disease (CJD) is a rare type of prion disease leading to a rapidly progressive dementia (RPD) and 
other associated neurological features specially startle myoclonus. The annual incidence of CJD has been reported 
2
to be 1 per million or 271 people in USA , but from Asia especially from Pakistan, only few case reports have been 
published.
The probable cause behind the rarity of this disease in our society is still unclear.The diagnosis of CJD requires 
a high level of suspicion and lack of the availability of speciﬁc markers like CSF 14-3-3 in our setup makes it 
more difﬁcult. Similarly brain biopsy is not an acceptable option for families of the sufferers because of the 
unavailability of the speciﬁc treatment.
To our knowledge this is the ﬁrst biopsy proven case of Crutzfeld Jacob disease (CJD) from Pakistan.
INTRODUCTION:
The prion diseases are deﬁned as a large group of 
related neurodegenerative conditions that affect both 
.  [1]
animals and humans Prion disease is a rare disease 
[2]
that has a prevalence of 1 in 1 million cases.  It has 
been reported infrequently from Asian countries. 
According to the recent case series from Aga khan 
university Hospital by Shazma khan et al.there were 
only 4 cases labeled as CJD from Pakistan till 2014 
and through retrospective record of AKUH from 1997 
till 2015, 12 cases were found to be labeled as CJD and 
[3]
only one was biopsy proven case.  We are reporting 
the case that has been conﬁrmed by brain biopsy to be 
deﬁnite CJD.
CASE HISTORY:
Our patient was a 69 years old female, who was not 
known to have any medical comorbid prior to her 
symptoms.She presented to Aga Khan University 
Hospital, Karachi with ﬁve months history of becoming 
progressively withdrawn and apathetic.There was two 
months history of gait unsteadiness and falls.She 
started to havemyoclonic jerks (especially of left upper 
limb), two weeks prior to presentation, that were 
followed by progressive unresponsiveness and ﬁnally 
she became bed bound.  
Her general physical exam was signiﬁcant for mild 
pallor, she was febrile. Neurologically, there was 
spontaneous eye opening, no eye contact with 
examiner or surroundings and no verbal output, 
neither she was able to follow commands, however 
brainstem responses (pupils, eye movements, 
spontaneous respiration) were preserved and she was 
able to localize deep pain from left hand, in other three 
limbs, there was ﬂexion withdrawal to deep pain.
Intermittent jerky movements were seen in left upper 
limb, aggravated by trivial stimuli. Deep tendon 
reﬂexes were +1, symmetrical with bilateral ﬂexor 
planters.
On blood testing, only positive ﬁnding was peripheral 
neutrophil leukocytosis with normal ECG although 
Chest X-ray was suggestive of aspiration pneumonia. 
Non contrast brain CT scan revealed generalized 
cerebral atrophy, which was conﬁrmed on MRI 
scan.C.S.F biochemistry was normal. EEG revealed 
periodic sharp complexes at approximately 
1.5Hz.Brain biopsy was done from nondominant 
f r o n t a l  p o l e  t h a t  r e v e a l e d  s p o n g i f o r m 
changes.Immuno-staining of biopsy sample with 3F4 
monoclonal antibody revealed granular deposits 
(speciﬁc for prion disease).
DISCUSSION:
Prion diseases arethe neurodegenerative diseases 
that usually have long incubation periods.Once the 
patient's clinical symptoms start, usually it progresses 
indeﬁnitely. Among the ﬁvedifferent human prion 
diseases recognized, CJD accounts for more than 90 
[4].
percent of sporadic prion disease 
The most of CJD cases are sporadic (85 to 95 percent), 
while 5 to 15 percent are due to familial CJD; iatrogenic 
[5, 6]
CJD generally accounts for less than 1 percent 
Classical sporadic CJD presents as rapidly 
progressivedementia usually associated with 
myoclonus.
Additional neurological features might include 
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pyramidaland extrapyramidal signs, cerebellar ataxia, 
and cortical blindness. The onset is usually in 
the45–75 years age group with median age at deathof 
[7]
68 years . The clinical progression is typicallyover 
weeks that can progress to akinetic mutism witha 
median disease duration of 5 months.
The diagnosis of CJD is suspected when patient 
presents with typical clinical symptoms and signs of 
[8].
rapidly progressing dementia with myoclonus further 
investigations to support the diagnosis include EEG 
showing characteristic generalized periodic sharp 
wave pattern and CSF analysis for 14-3-3 
protein.However, the deﬁnitive diagnosis for prion 
disease is only by the biopsy of brain tissue. A negative 
biopsy does not necessarily rule out CJD, as it may 
[9]
predominate in a speciﬁc part of the brain. .
CONCLUSION
This report conﬁrms the presence in our population of 
Creutzfeldt - Jacob disease, an uncommon but 
important cause of dementia.
While clinical and EEG features suggest the diagnosis, 
conﬁrmation requires biopsy or autopsy. 
A high index of suspicion and low threshold for biopsy 
examination are needed to deﬁne the burden of CJD in 
Pakistan.
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Figure 1: 
MRI Brain showing generalized 
brain atrophy.
P A K I S T A N  J O U R N A L O F N E U R O L O G I C A L S C I E N C E S V O L . 1  ( ) J A N - M A R 2 0 1 83 13 4
Figure 3:    Brain biopsy 
Showing spongiform changes and 3F4 monoclonal antibody revealed granular deposits
Figure 2: 
EEG showing period sharp 
complexes at approximately 1.5 Hz
Brain biopsy (GFAP) 20X Brain biopsy (H&E) 40X
Conﬂict of interest: Author declares no conﬂict of interest.
Funding disclosure: Nil
Author's contribution:
Rizwana Shahid; concept, data collection, data analysis, manuscript writing, manuscript review
Saad Shafqat; concept, data collection, data analysis, manuscript writing, manuscript review
